Fundamentals of Analytical Toxicology. Robin Whelpton

Fundamentals of Analytical Toxicology - Robin Whelpton


Скачать книгу
Sample transport, storage, and disposal

       Name of the individual collecting the specimen(s)

       Name of each person or entity subsequently having custody of it, and details of how it has been stored

       Date(s) the specimen(s) collected or transferred

       Specimen or post-mortem number(s)

       Name of the subject or deceased

       Brief description of the specimen(s)

       Record of the condition of tamper-evident seals

      Fully validated assays must include data on the stability of the analyte under specified sample collection and storage conditions (van de Merbel et al., 2014; Reed, 2016). In the absence of other information, biological specimens should be stored at 2–8 °C prior to analysis, if possible, and ideally any specimen remaining after the analysis should be kept at 2–8 °C for 3–4 weeks in case further analyses are required. In view of the medico-legal implications of some poison cases (for example, if it is not clear either how the poison was administered, or if the patient dies) then any specimen remaining should be kept (preferably at –20 °C) until investigation of the incident is concluded. Unfortunately, there are few stability data for whole blood specimens, let alone for post-mortem specimens.

Volatile agents Aerosol propellants, anaesthetic gases, carbon monoxide, cyanide, ethanol, ethchlorvynol, mercury, methanol, nicotine, organic solvents, paraldehyde, volatile nitrites (amyl nitrite, etc.)
Non-volatile substances Acyl (ester) glucuronides, amiodarone, aspirin, bupropion, carbamate esters (e.g. physostigmine, pyridostigmine), ciclosporin,a cyanide, esters (e.g. 6-AM, benzocaine, cocaine, diltiazem, diamorphine, GHB, pethidine, methylphenidate, procaine, succinylcholine), N-glucuronides (e.g. olanzapine N-glucuronide), insulins, insulin C-peptide, LSD, nitrobenzodiazepines (clonazepam, flunitrazepam, loprazolam, nitrazepam and their 7-amino metabolites), glyceryl trinitrate and other nitrates and nitrites, nitrophenylpyridines (e.g. nifedipine, nisoldipine), olanzapine, N-oxide metabolites, S-oxide metabolites, paracetamol, peroxides and other strong oxidizing agents, phenelzine, phenothiazines,b piperazines, proinsulin, quinol metabolites (e.g. 4-hydroxypropranolol), rifampicin, sirolimus,a N-sulfate metabolites (e.g. minoxidil N-sulfate), tacrolimus,a thalidomide, thiol-containing drugs (e.g. captopril), thiopental, zopiclone

      aRedistributes between plasma and erythrocytes on standing (use whole blood)

      bParticularly those without an electronegative substituent at the 2-position

      Stabilization by addition of a reducing agent such as ascorbate or sodium metabisulfite has been advocated in some cases (Sørensen & Hasselstrøm, 2019), but is not performed routinely and in the case of olanzapine, for example, there is the possibility of reducing the N-oxide by such an addition. The monographs in the compendium by Baselt (2020) detail such stability data as there are for many compounds.

       Do not freeze whole blood if plasma or serum is to be analyzed

       Ensure that labelling is waterproof

       Ensure tubes are tightly sealed and well filled, but do not overfill tubes, especially glass tubes

       Do not keep too long to minimize freeze-drying effects

       Keep a record of freezer contents and freezer cleaning

       Keep a continuous record of freezer temperature via an electronic device

       Use a spark-proof freezer if flammable materials may be stored

       Fit an alarm in case of freezer failure

       Implement a defined sample disposal policy in collaboration with stakeholders


Скачать книгу